GlaxoSmithKline shares jumped 3 percent after the U.K.-listed pharmaceutical giant reported second-quarter earnings per share that were slightly higher than forecast on Wednesday.» Read More
New York's subway system, among the busiest in the world, carries more commuters than previously thought: researchers have identified 562 species of bacteria in the city's subway stations.
Facebook CEO Mark Zuckerberg and his wife just donated $75 million to this institution.
When a big data breach hit Target, shoppers headed to other stores. Now Anthem is in a similar position, but switching insurers is more complicated.
Hackers who carried out the massive Anthem data breach may not have cracked the company's systems for profit.
Cocaine users seem to not to feel the losses associated with bad predictions, and this may mean their brains have more trouble learning from mistakes.
Pfizer is buying Hospira, which calls itself the world's leading provider of injectable drugs and infusion technologies. So what the heck are they?
President Obama's cybersecurity adviser said he was concerned about a data breach at health insurer Anthem that has affected up to 80 million people.
Anthem has disclosed that a database containing personal information for about 80 million of its customers and employees was hacked, CNBC has confirmed.
Pfizer on Thursday said it plans to acquire Hospira for $90 a share in cash, in a deal the companies valued at about $17 billion.
The World Health Organization reports that 113 countries have higher immunization rates than the United States for 1-year-olds.
Under Armour is creating a digital health and fitness community powerhouse, CEO Kevin Plank tells CNBC.
AstraZeneca reported a loss for the fourth quarter of 2014, but stressed that it was on track to return to growth by 2017.
Will poisoned politics get in the way of a resolution to the Obamacare challenge headed to the Supreme Court?
The number of people who selected a 2015 Obamamacare plan is now more than 10 million nationally after sign-up tallies were updated Wednesday.
In 17 states, less than 90 percent of children aged 19-to-35 months have gotten recommended vaccinations against measles, mumps and rubella.
Discounts on Gilead's hepatitis C drugs this year will be 46 percent, way more than investors and analysts expected.
Gilead Sciences posted strong sales of its hepatitis C drugs Harvoni and Sovaldi, sending its net profit up more than four-fold for the quarter.
The scientific community has thoroughly debunked any association behind autism and vaccination, Dr. Scott Gottlieb tells CNBC.
Shares of GlaxoSmithKline jumped on Wednesday, despite the company posting a 3 percent fall in full-year revenue.
Merck said the U.S. FDA intends to rescind its "breakthrough" designation for its experimental combination treatment for hep C.
Get the best of CNBC in your inbox